RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 115 filers reported holding RELAY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $746,625 | -23.0% | 114,513 | -2.0% | 0.00% | – |
| Q1 2024 | $970,128 | -40.1% | 116,883 | -20.5% | 0.00% | – |
| Q4 2023 | $1,619,362 | +25.6% | 147,081 | -4.1% | 0.00% | – |
| Q3 2023 | $1,289,321 | -19.1% | 153,308 | +20.8% | 0.00% | – |
| Q2 2023 | $1,593,662 | +30.8% | 126,884 | +71.6% | 0.00% | – |
| Q1 2023 | $1,218,005 | +38.5% | 73,953 | +25.6% | 0.00% | – |
| Q4 2022 | $879,488 | -32.0% | 58,868 | +1.8% | 0.00% | – |
| Q3 2022 | $1,294,000 | +34.0% | 57,807 | +0.3% | 0.00% | – |
| Q2 2022 | $966,000 | -39.5% | 57,619 | +8.1% | 0.00% | – |
| Q1 2022 | $1,596,000 | +74.0% | 53,326 | +78.7% | 0.00% | – |
| Q4 2021 | $917,000 | +6.1% | 29,835 | +8.9% | 0.00% | – |
| Q3 2021 | $864,000 | +1.4% | 27,395 | +17.7% | 0.00% | – |
| Q2 2021 | $852,000 | +158.2% | 23,277 | +143.7% | 0.00% | – |
| Q1 2021 | $330,000 | +13.4% | 9,552 | +36.4% | 0.00% | – |
| Q4 2020 | $291,000 | – | 7,004 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 5,998,574 | $75,342,089 | 6.58% |
| Nextech Invest Ltd. | 948,659 | $11,915,157 | 4.05% |
| MPM BioImpact LLC | 1,354,368 | $17,010,862 | 3.42% |
| Finepoint Capital LP | 701,570 | $8,811,719 | 3.05% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $350,486,335 | 2.67% |
| EcoR1 Capital, LLC | 4,163,824 | $52,297,629 | 1.28% |
| BVF INC/IL | 3,120,521 | $39,193,744 | 1.09% |
| Integral Health Asset Management, LLC | 700,000 | $8,792,000 | 1.09% |
| Boxer Capital, LLC | 1,819,132 | $22,848 | 1.06% |
| Alphabet Inc. | 1,568,753 | $19,703,537 | 1.06% |